PTPN11 and melanoma: Furthermore, the development of B16-F10 melanoma and MC17-51 fibrosarcoma in mice was inhibited by the myeloid-specific deletion of SHP2, and the immunosuppressive potential of myeloid-derived suppressive cells against tumors was decreased (174).